Prevalence and characteristics associated with metabolic syndrome in Japanese-Brazilians with and without periodontal disease;Prevalência e características associadas à síndrome metabólica em nipo-brasileiros com e sem doença periodontal

Cadernos de Saude Publica

Volumn 23, Issue 3, 2007, Pages 657-668

  Borges, Pollyanna Kássia De Oliveira ^a   Gimeno, Suely Godoy Agostinho ^a   Tomita, Nilce Emy ^b   Ferreira, Sandra Roberta ^a   Barros Jr , N ^c   Cardoso, M A ^c   Chaim, R ^c   D'Almeida, V ^c   Franco, L J ^c   Harima, H ^c   Hirai, A ^c   Hirai, A T ^c   Kikuchi, M ^c   Matsumura, L ^c   Moises R S ^c   Osiro, K ^c   Wakisaka, K ^c  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE

Author keywords

Diabetes mellitus; Dyslipidemias; Metabolic syndrome X; Obesity; Periodontal diseases

Indexed keywords

ADULT; ARTICLE; ASIAN; BODY MASS; BRAZIL; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; GINGIVITIS; HUMAN; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOUTH DISEASE; OBESITY; PERIODONTAL DISEASE; PERIODONTITIS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; BRAZIL; EPIDEMIOLOGIC METHODS; FEMALE; GINGIVITIS; HUMANS; JAPAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOUTH, EDENTULOUS; OBESITY; PERIODONTAL DISEASES; PERIODONTITIS;

EID: 33847675497     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2007000300024     Document Type: Article

References (64)

1. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: World Health Organization; 1999.
2. National Cholesterol Education Program. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adults Treatment Panel III). JAMA 2001; 285:2486-97.
3. Grundy SM, Brewer Jr. HB, Cleeman JI, Smith Jr. SC, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109:433-8.
4. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-607.
5. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993; 44:121-31.
6. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288:2709-16.
7. Rosenbaum P, Gimeno SGA, Sanudo A, Franco LJ, Ferreira SRG. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians 2005. Diabetes Obes Metab 2005; 7:352-9.
8. International Diabetes Federation/World Health Organization. The IDF consensus worldwide definition of the metabolic syndrome, 2005. http://www.idf.org/webcast/pdf/IDF_backgrounder_1.pdf (acessado em 10/Mai/2005).
9. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156:1070-7.
10. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-9.
11. Meigs JB, Wilson PWF, Nathan DM, D'Agostino RB, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003; 52:2160-7.
12. Shimamoto K. Epidemiologic study on metabolic syndrome - comparison between Japan and western countries. Nippon Rinsho 2004; 62:1053-8.
13. Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, et al. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Diabetes Care 2005; 28:1463-71.
14. Lerario DG, Gimeno SGA, Franco LJ, Iunes M, Ferreira SRG. Prevalence of weight excess and implications of abdominal fat distribution for the metabolic syndrome in Japanese-Brazilians. Rev Saúde Pública 2002; 36:4-11.
15. Gimeno SGA, Ferreira SRG, Franco LJ, Hirai AT, Matsumura L, Moisés RS. Prevalence and 7-year incidence of Type II diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. Diabetologia 2002; 45:1635-8.
16. Esposito K, Marfella R, Ciotola M, Palo C, Giugliano F, Giugliano G, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292:1440-6.
17. Elkind MSH, Rundek T, Sciacca RR, Ramas R, Chen HJ, Boden-Abdala B, et al. Interleukin-2 levels are associated with carotid artery intima-media thickness. Atherosclerosis 2005; 180:181-7.
18. Erdmann E. Diabetes and cardiovascular risk markers. Curr Med Res Opin 2005; 21:521-8.
19. Fantuzzi G. Adipose tissue, adipokines, and inflamation. J Allergy Clin Immunol 2005; 115:911-9.
20. American Academy of Periodontology. The pathogenesis of periodontal disease. J Periodontol 1999; 70:457-70.
21. a Ed. Rio de Janeiro: Editora Guanabara Koogan; 1997.
22. Lindhe J. Tratado de periodontia clínica e implantologia oral. Rio de Janeiro: Editora Guanabara Koogan; 1992.
23. Anonymous. Consensus report. Periodontal disease: epidemiology and diagnosis. Ann Periodontol 1996; 1:216-22.
24. American Academy of Periodontology. Periodontal disease as a potential risk factor for systemic disease. J Periodontol 1998; 69:841-50.
25. Albandar JM, Rams TE. Global epidemiology of periodontal disease: an overview. Periodontol 2000 2002; 29:7-10.
26. Kigman A, Albandar JM. Methodological aspects of epidemiological studies of periodontal disease. Periodontol 2000 2002; 29:11-30.
27. Clarkson JJ, McLoughlin J. Role of fluoride in oral health promotion. Int Dent J 2000; 50:119-28.
28. Page RC. The pathobiology of periodontal diseases may affect systemic disease: inversion of a paradigm. Ann Periodontol 1998, 3:108-20.
29. Nishimura F, Murayama Y. Periodontal inflammation and insulin resistance - lessons from obesity. J Dent Res 2001; 80:1690-4.
30. Uysal KT, Wiesbrock SM, Marino MW, Hotamisgil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alfa function. Nature 1997; 389:610-4.
31. Ferreira SR, Iunes M, Franco LJ, Iochida LC, Hirai A, Vivolo MA. Disturbances of glucose and lipid metabolism in first and second generation Japanese-Brazilians. Japanese-Brazilian Diabetes Study Group. Diabetes Res Clin Pract 1996; 34 Suppl:S59-63.
32. Tomita NE, Chinellato LE, Pernambuco RA, Lauris JR, Franco LJ; Grupo de Estudo Diabetes em Nipo-Brasileiros. Condições periodontais e diabetes mellitus na população nipo-brasileira. Rev Saúde Pública 2002; 36:607-13.
33. Pernambuco RA. Diabetes mellitus e condições periodontais na população nipo-brasileira de Bauru-SP-Brasil [Dissertaç ão de Mestrado]. Bauru: Faculdade de Odontologia, Universidade de São Paulo; 2001.
34. World Health Organization/International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment, 2000. http://www.wpro.who.int/NR/rdonlyres/B924BFA6-A061-43AE-8DCA-0AE82A8F66D2/0/ obesityinthepacific.pdf (acessado em 15/Out/2005).
35. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-9.
36. Pfeiffer CM, Huff DL, Gunter EW. Rapid and accurate HPLC assay for plasma total homocysteine and cysteine in a clinical laboratory setting. Clin Chem 1999; 45:290-2.
37. World Health Organization. Oral health surveys - basic methods. Geneva: World Health Organization; 1997.
38. a Ed. São Paulo: Editora Santos; 2000.
39. Anonymous. Parameter on plaque-induced gingivitis. American Academy of Periodontology. J Periodontol 2003; 71 (5 Suppl):851-2.
40. Hosmer JR, Lemeshow S. Applied logistic regression. New York: John Wiley & Sons; 1989.
41. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. http://www.wma.net/e/policy/b3. htm (acessado em 27/Nov/2005).
42. Oppermann R, Rosing CK, Gjermo P, Susin C. Periodontal disease in Central and South America. Periodontol 2000 2002; 29:70-8.
43. Miyazaki H, Hanada N, Andoh MI, Yamashita Y, Saito T, Sogame A, et al. Periodontal disease prevalence in different age groups in Japan, as assessed according to the CPITN. Community Dent Oral Epidemiol 1989; 17:71-4.
44. Ministério da Saúde. Condições de saúde bucal na população brasileira 2002-2003. Brasília: Ministério da Saúde; 2005.
45. Burt B; Research, Science and Therapy Committee of the American Academy of Periodontology. Position paper: epidemiology of periodontal disease. J Periodontol 2005; 76:1406-19.
46. Hidalgo FR. Smoking and periodontal disease. Periodontol 2000 2003; 32:50-8.
47. Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. J Periodontol 2000; 71:743-51.
48. Bergstrom J, Eliasson S, Dock J. Tobacco use as risk factor. J Periodontol 1994; 65 Suppl:545-50.
49. Shah N, Parkash H, Sunderam KR. Edentulousness, denture wear and denture needs of Indian elderly - a community-based study. J Oral Rehabil 2004; 31:467-76.
50. Nunn ME. Understanding the etiology of periodontitis: an overview of periodontal risk factors. Periodontol 2000 2003; 32:11-23.
51. Page RC, Sturdivant EC. Non-inflammatory destructive periodontal disease (NDPD). Periodontol 2000 2002; 30:24-39.
52. Ritchie CS, Kinane DF. Nutrition, inflammation, and periodontal disease. Nutrition 2003; 19:475-6.
53. Research, Science and Therapy Committee, American Academy of Periodontology. Periodontal management of patients with cardiovascular disease. J Periodontol 2002; 73:954-68.
54. Hobdell M, Petersen PE, Clarkson J, Johson N. Global goal for oral health 2020. Int Dent J 2003; 53:285-8.
55. Knowler WC, Pettitt DJ, Saad MF, Bennet PH. Diabetes mellitus in Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990; 6:1-27.
56. Grossi SG, Skrepcinski FB, DeCaro T, Zambon JJ, Cummins D, Genco RJ. Response to periodontal therapy in diabetics and smokers. J Periodontol 1996; 67:1094-102.
57. Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 1996; 67:1085-93.
58. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russel CM. Dental disease and risk of coronary heart disease. BMJ 1993; 306:688-91.
59. Katz J, Chaushu G, Sharabi Y. On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease. J Clin Periodontol 2001; 28:865-8.
60. Losche W, Karapetow F, Pohl A, Kocher T. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol 2000; 27:537-41.
61. Nishimura F, Murayama Y. Periodontal inflammation and insulin resistance- lessons from obesity. J Dent Res 2001; 80:1690-4.
62. Iwamoto Y, Nishimura F, Nakagawa M, Sugimoto H, Shikata K, Makino H, et al. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001; 72:774-8.
63. Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-alpha in 2-way relationship. J Periodontol 2003; 74:97-102.
64. Nishimura F, Soga Y, Iwamoto Y, Kudo C, Murayama Y. Periodontal disease as part of the insulin resistance syndrome in diabetic patients. J Int Acad Periodontol 2005; 7:16-20.